| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |